This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

The value of diagnostic testing for SARS-CoV-2: When, whom, what and how often to test?

March 30th, 2020
lab test
Credit: CC0 Public Domain

As we enter the second quarter of the COVID-19 pandemic, with testing for SARS-CoV-2 increasingly available (though still limited and slow in some areas), clinicians and public health officials are faced with new questions and challenges regarding testing for this novel virus. Since SARS-CoV-2 is a new virus, there is little evidence to fall back on for test utilization and diagnostic stewardship. New research published in mBio, an open-access journal of the American Society for Microbiology, addresses the potential uses of two main types of tests.

ASM convened a summit of coronavirus experts on Monday, March 23rd, who summarized the value and potential uses of two types of tests for SARS-CoV-2, nucleic acid amplification tests for viral RNA and antibody detection tests. The authors, including ASM CEO Stefano Bertuzzi and ASM President Robin Patel, also spoke at a press conference the following day and offered recommendations and limitations for both types of tests.

More information:
Robin Patel et al. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19. mBio DOI: 10.1128/mBio.00722-20

Provided by American Society for Microbiology

Citation: The value of diagnostic testing for SARS-CoV-2: When, whom, what and how often to test? (2020, March 30) retrieved 28 March 2024 from https://sciencex.com/wire-news/347020539/the-value-of-diagnostic-testing-for-sars-cov-2-when-whom-what-an.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.